These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1732381)
1. Effects of chloroquine on antigen-presenting functions of epidermal cells from normal and psoriatic skin. Demidem A; Taylor JR; Grammer SF; Streilein JW J Invest Dermatol; 1992 Feb; 98(2):181-6. PubMed ID: 1732381 [TBL] [Abstract][Full Text] [Related]
2. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells. Demidem A; Taylor JR; Grammer SF; Streilein JW J Invest Dermatol; 1991 Sep; 97(3):454-60. PubMed ID: 1875046 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis. Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells. Cai JP; Falanga V; Taylor JR; Chin YH J Invest Dermatol; 1992 Apr; 98(4):405-9. PubMed ID: 1548425 [TBL] [Abstract][Full Text] [Related]
5. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367 [TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis. Demidem A; Taylor JR; Grammer SF; Streilein JW J Invest Dermatol; 1991 Apr; 96(4):401-7. PubMed ID: 1826121 [TBL] [Abstract][Full Text] [Related]
7. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity. Horrocks C; Holder JE; Berth-Jones J; Camp RD Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222 [TBL] [Abstract][Full Text] [Related]
9. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195 [TBL] [Abstract][Full Text] [Related]
10. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis. Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841 [TBL] [Abstract][Full Text] [Related]
11. Organ culture of psoriatic skin: effect of TGF-alpha and TGF-beta on epidermal structure in vitro. Kondo S; Hozumi Y; Maejima H; Aso K Arch Dermatol Res; 1992; 284(3):150-3. PubMed ID: 1503499 [TBL] [Abstract][Full Text] [Related]
12. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1. Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165 [TBL] [Abstract][Full Text] [Related]
13. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells. Prens EP; Benne K; van Joost T; Benner R J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638 [TBL] [Abstract][Full Text] [Related]
14. Differential localization of TGF-beta-precursor isotypes in psoriatic human skin. Wataya-Kaneda M; Hashimoto K; Kato M; Miyazono K; Yoshikawa K J Dermatol Sci; 1996 Mar; 11(3):183-8. PubMed ID: 8785168 [TBL] [Abstract][Full Text] [Related]
15. Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells. Jensen AM; Lladó MB; Skov L; Hansen ER; Larsen JK; Baadsgaard O Br J Dermatol; 1998 Dec; 139(6):984-91. PubMed ID: 9990360 [TBL] [Abstract][Full Text] [Related]
16. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD J Invest Dermatol; 1995 Jul; 105(1 Suppl):89S-94S. PubMed ID: 7616005 [TBL] [Abstract][Full Text] [Related]
17. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Ashworth J; Booker J; Breathnach SM Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin. Liu R; Wang Y; Zhao X; Yang Y; Zhang K Eur J Dermatol; 2014; 24(5):560-7. PubMed ID: 25445090 [TBL] [Abstract][Full Text] [Related]
19. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168 [TBL] [Abstract][Full Text] [Related]
20. Chloroquine inhibits accessory cell presentation of soluble natural and synthetic protein antigens. Buus S; Werdelin O Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):285-91. PubMed ID: 6334972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]